1. Home
  2. BTU vs GPCR Comparison

BTU vs GPCR Comparison

Compare BTU & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peabody Energy Corporation

BTU

Peabody Energy Corporation

HOLD

Current Price

$24.24

Market Cap

3.2B

Sector

Energy

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$45.61

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTU
GPCR
Founded
2016
2016
Country
United States
United States
Employees
6600
N/A
Industry
Coal Mining
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
2001
2023

Fundamental Metrics

Financial Performance
Metric
BTU
GPCR
Price
$24.24
$45.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$32.83
$103.17
AVG Volume (30 Days)
3.7M
755.7K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
1.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,861,500,000.00
N/A
Revenue This Year
$17.96
N/A
Revenue Next Year
$5.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.67
$15.80
52 Week High
$41.14
$94.90

Technical Indicators

Market Signals
Indicator
BTU
GPCR
Relative Strength Index (RSI) 39.48 64.42
Support Level N/A $42.72
Resistance Level $31.39 $57.23
Average True Range (ATR) 1.38 2.26
MACD -0.40 0.86
Stochastic Oscillator 4.78 84.34

Price Performance

Historical Comparison
BTU
GPCR

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan, and other regions.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: